Thousand Oaks, California -April 29, 2019 - THC Farmaceuticals, Inc (OTCMARKETS:CBDG) is developing a telemedicine platform called MyCBD.MD to help provide telehealth services to patients who are unable or unwilling to see a doctor in person or are seeking to learn more about cannabidiol (CBD) and to try CBD based formulations as a part of their alternative medicine plans to improve their health. Services will be provided by US licensed and Board-certified doctors. Telehealth is a rapidly expanding mode of health care service delivery in North America.
The platform, MyCBD.MD, will be pilot testing ZOOM’s telehealth technology for 60 days. Zoom telehealth platform allows MyCBD.MD to offer telemedicine to its patients in a HIPPA complaint environment. Zoom does not have access to any patient health information (PHI) and all audio, video and screen sharing data is encrypted.
Zoom allows for HD video and audio clarity and quality for each telemedicine visit. Patients can be treated from virtually anywhere from any device at their own convenience. Services will be available via smartphones, tablets and desktop computers.
MyCBD.MD is now testing the Zoom telemedicine capabilities to develop a new virtual health care solution that will connect patients to healthcare providers that are experienced with cannabidiol.
“The CBD industry is quickly evolving, and we see an opportunity to bring care and credible knowledge to patients in a convenient manner,” according to Dr. Rubin.
Follow us on Twitter @THCFarma
About THC Farmaceuticals, Inc.
THC Farmaceuticals, Inc., (OTC:CBDG) through its subsidiary, CBDual Biotechnology Corp., is a US based Biotechnology company with advanced formulations for the commercialization of bioactive cannabinoids for oral hygiene and other pharmaceutical formulations.
The company was founded by Dr. Greg Rubin, a veteran in the health care industry, with 35 years of experience. Dr. Rubin holds several patents, is an inventor and manufacturer of healthcare products.
For additional information visit the company's website: http://cbdg.com/.
Forward-Looking Statements:
This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.